Dr. Barry W. Goy explains how to interpret PSA levels after prostate cancer treatment and how to manage recurrence based on disease progression. Among patients with intermediate-risk prostate cancer, ...

levels and time to nadir PSA (TnPSA) following radiotherapy have been proposed as predictors of outcome in prostate cancer. Ray et al. attempted to determine the importance of these parameters as ...

There is a general consensus among clinicians that a serum prostate-specific antigen (PSA) level ≥4.0 ng/ml is predictive of prostate cancer, and necessitates a biopsy. But there is a dearth of ...

Background. Primary androgen deprivation therapy (PADT) is the most effective systemic therapy for patients with metastatic prostate cancer. Nevertheless, once PSA progression develops, the ...

Previous studies have shown that there is an association between serum PSA level and prostate volume in men without prostate cancer. Most of these studies, however, were performed in Western ...

Higher PSA levels may indicate that there is a problem with the prostate, such as: Prostate cancer Benign prostatic ...

High pre-treatment PSA levels correlate with increased recurrence and treatment failure in intermediate-risk prostate cancer patients treated with HIFU. Gleason grade 3 or higher is associated with ...

The researchers tracked which of the men were diagnosed with prostate cancer after receiving a test result showing raised levels of PSA. More than 80 percent of the men had normal PSA levels ...

PSA is a protein produced by normal cells in the prostate, but also by prostate cancer cells. It’s normal to have a small amount of PSA in your blood, and as you get older and your prostate gets ...

The NHS does not offer routine prostate-specific antigen (PSA) blood testing for prostate cancer, but says people may be offered the test if their doctor thinks they have symptoms of the disease.